ARNAV Biotech Corp.


Arnav Biotech is a multi-disciplinary company focused on developing efficient mRNA-based drug discovery, therapeutics, vaccines, and diagnostic applications. They offer high-quality, custom, and catalogued mRNA products, with expertise in mRNA design, optimization, and synthesis. The company collaborates on innovative projects such as developing anti-viral therapeutics and mRNA platform technologies, aiming to bring advanced solutions to healthcare and research sectors.

Industries

biotechnology
health-care
life-science

Nr. of Employees

small (1-50)

ARNAV Biotech Corp.

Columbus, Georgia, United States, North America


Products

Pre-designed capped and polyadenylated mRNA for screening

Ready-to-use, fully capped and polyadenylated mRNA constructs intended for screening delivery formulations in vitro and in vivo.

Reporter mRNA (luminescent and fluorescent)

mRNA constructs encoding luciferase and fluorescent proteins optimized for rapid expression and use in transfection efficiency assays, whole-body imaging, and biodistribution studies.

Functional enzyme-encoding mRNA

mRNA constructs encoding functional enzymes (examples include recombinase and beta-galactosidase) for use in functional screening, reporter activation, selection marker removal, and imaging assays.

Multi-epitope-tagged mRNA constructs

mRNA constructs engineered to include multiple epitope tags to permit orthogonal detection and affinity purification using standard immunoassays and tag-based methods.


Services

Custom mRNA synthesis

Contract synthesis of user-designed or company-designed mRNA with options for base modifications, cap structures, poly(A) tails, phosphatase treatment, and selectable resuspension buffers.

Catalog mRNA supply (control, reporter, functional constructs)

Off-the-shelf research mRNAs including reporter constructs (luminescent and fluorescent), functional enzymes (recombinase, beta-galactosidase), and multi-tagged constructs for detection and purification.

Process development and purification platform collaboration

Development of synthesis and purification processes that combine chromatographic purification and in-process analytics to improve yield and purity for mRNA therapeutics.

Preclinical development and IND-enabling support

Support services aimed at progressing candidates to pre-IND and IND-enabling studies, including biological testing and process readiness for regulatory submission activities.

Expertise Areas

  • mRNA design and optimization
  • Custom mRNA manufacturing
  • mRNA purification and analytics
  • Process development and scale-up for mRNA
  • Show More (4)

Key Technologies

  • mRNA synthesis
  • Modified nucleoside incorporation
  • 5' capping methods
  • Poly(A) tail engineering
  • Show More (6)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.